Advancing Real-World Evidence Generation for Causal Inference online training

    Advancing Real-World Evidence Generation for Causal Inference

    “Regulatory-Grade” RWE for Causal Inference to Support Healthcare Decision-Making

    2 – 4 October 2023, live online training


    This interactive course is focused on the next generation of advancing RWE and offers delegates an in-depth discussion on the strategic applications of causal RWE and cutting-edge tools to design and implement the highest-quality, i.e., “regulatory-grade” RWD and RWE, embedded in a pre-and post-approval clinical development plan.

    Learning Objectives

    • Understand the fundamentals of leading-edge causal RWE and comparative effectiveness
    • Discuss the strategic applications of causal RWE throughout the product lifecycle
    • Design causal RWE studies that will support regulatory and payer/HTA decision-making
    • Review the most current RWE guidance, cutting-edge tools, and good research practices
    • Implement causal research projects that will generate the highest quality RWD & RWE

    Key Topics

    • RWE for causal inference – leading-edge research
    • Strategic applications of causal RWE
    • Supporting regulatory benefit/risk decision-making
    • RWE for payer/HTA value and pricing evidence
    • Guidance, cutting-edge tools, and good research practices
    • Designing and implementing fit-for-purpose causal RWE research

    Who should attend?

    Real-World Evidence, Centre of excellence and functional leads, Rare disease, OMP and ATMP executives and functional leads, Chief Science Officers, Clinical Development and Program Directors with an interest in RWE, Medical Affairs executives, Pricing, and Market access executives, Marketing and Commercial leaders, Patient centricity, COA and PRO leads

    Past participants

    • IVS Head, AstraZeneca
    • Global Clinical Leader, Bayer
    • Head of Market Access & Pricing, Merck Group
    • Rare Diseases Lead Adriatic, Pfizer
    • Patient Value & Acces Head, Takeda

    Our online training experience includes

    • Our client zone – a single source for all training materials as well as pre and post-training communication
    • Live interactive format via the Zoom platform
    • Direct interaction with the trainer
    • Q&As, case studies, polls
    • Revisit recorded sessions for 30 days
    • Digital and LinkedIn certificates


    David Schwicker has biopharmaceutical consulting expertise spanning more than 25 years. Founder of ORPHA Strategy Consulting, and former Vice President with PAREXEL International in the United States. David is a sought-after expert for accelerating marketing authorization, time to launch, early patient and market access of ATMPs.

    Advancing Real-World Evidence Generation for Causal Inference

    Download the full training agenda to reveal complete session details, training takeaways, case studies, daily schedule, special features and full trainer bio.

    Online Participation
    1 850  Price incl. VAT: 1 850 
    Equivalent of approx. 2 071 USD.
    The price calculation in USD is informative and might slightly differ from your bank exchange rate

    Price per delegate includes:

    Online workbook & materials

    Access to client zone

    Recorded sessions for 7 days


    PC, microphone, camera, stable internet connection and the Zoom application.

    Yes, we will make every effort to ensure best possible interaction. You will see the slides, interact with the trainer and fellow participants. Questions and group exercises will be facilitated through the online meeting platform.

    Yes, you can transfer the registration to a colleague at any time.

    Yes, you may transfer your registration to a different event up to one month before the scheduled dates, provided the training fee has been paid in full.

    pharma learning leader

    Lydia Makori
    +421 222 200 543

    Training Details
    • Start Date
      2. October 2023
      01:00 PM Vienna time
      12:00 PM London time
      07:00 AM New York time
      04:00 AM Los Angeles time
    • End Date
      4. October 2023
    What participants said about this course

    "Extremely knowledgeable speaker, the whole meeting was great"
    Evidence Generation Lead, UCB

    "Trainer very clear and prepared. Excellent meeting."
    Health Economics & Market Access Manager, Pfizer Hellas

    "Great expertise of the speaker and practical examples how this has been done by other companies. Also outlook, where the trends in RWE are (likely) going."
    Head Public Affairs & Public Policy, Takeda